SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS
The invention provides for a vaccine against S. suis serotype 2. The vaccine comprises chemically synthesized fragments and thus may be made widely commercially available. The vaccine is used in the livestock production and may be adapted for use against other serotypes of S. suis such as serotypes 1, 1/2, 3, 9, and 14. Also, the vaccine may be adapted for use in humans..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 04. Mai Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SEGURA MARIELA [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-05-04, Last update posted on www.tib.eu: 2023-08-16, Last updated: 2023-08-18 |
---|
Patentnummer: |
WO2023070223 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA017249902 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA017249902 | ||
003 | DE-627 | ||
005 | 20230818085814.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230623s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA017249902 | ||
035 | |a (EPA)WO2023070223 | ||
035 | |a (EPA)86159903 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SEGURA MARIELA |e verfasserin |4 aut | |
245 | 1 | 0 | |a SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-05-04, Last update posted on www.tib.eu: 2023-08-16, Last updated: 2023-08-18 | ||
520 | |a The invention provides for a vaccine against S. suis serotype 2. The vaccine comprises chemically synthesized fragments and thus may be made widely commercially available. The vaccine is used in the livestock production and may be adapted for use against other serotypes of S. suis such as serotypes 1, 1/2, 3, 9, and 14. Also, the vaccine may be adapted for use in humans. | ||
650 | 4 | |a cet | |
650 | 4 | |a C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C08B: Polysaccharides; derivatives thereof (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages c07h;fermentation or enzyme-using processes c12p0019000000;production of cellulose d21) | |
650 | 4 | |a 615 | |
700 | 0 | |a GOTTSCHALK MARCELO |4 aut | |
700 | 0 | |a LOWARY TODD |4 aut | |
700 | 0 | |a LI PEI-JHEN |4 aut | |
700 | 0 | |a JANA MANAS |4 aut | |
700 | 0 | |a LO FIEGO MARCOS |4 aut | |
700 | 0 | |a SWEENEY RYAN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 04. Mai |
773 | 1 | 8 | |g year:2023 |g day:04 |g month:05 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86159903/publication/WO2023070223A1?q=WO2023070223 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 04 |c 05 |
951 | |a AR | ||
952 | |j 2023 |b 04 |c 05 |